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HIV infection results in an early and profound loss of
Vg2Vd2 T cells, and this is the only T cell receptor-specific
depletion that is common to all individuals with HIV/
AIDS. A similar pattern of Vg2Vd2 T cell depletion occurs
in mycobacterium infection and during malaria. We
hypothesize that the loss of Vg2Vd2 T cells, irrespective of
the primary cause for this loss, results in disease accelera-
tion during HIV+ tuberculosis or HIV+ malaria coinfec-
tions and also leads to increased incidence of cancer in the
context of HIV/AIDS.
Using a macaque model for mycobacterium infection, we
demonstrated the dynamics of Vg2Vd2 responses to infec-
tion with attenuated M. bovis (BCG). In this study, we
confirmed that activation-induced cell death is the mech-
anism for Vg2Vd2 T cell depletion in vivo, and confirmed
this with in vitro studies using human T cells. In vitro
studies with human PBMC allowed us to understand the
specificity of T cell receptor recognition of human lym-
phomas. Using AIDS-related and non-AIDS related B
NHL, we defined the T cell receptor structures required for
tumor recognition and showed they are indeed, missing
in HIV-infected individuals. Lastly, we evaluated longitu-
dinal specimens from HIV-infected individuals receiving
HAART and showed that recovery of the Vg2 repertoire
was occurring by the use of previously rare sequences that
survived initial HIV-mediated depletion and were
expanded during the treatment interval. Importantly, rep-
ertoire recovery occurred in the absence of new cell syn-
thesis, consistent with observations on CD4 and CD8 T
cell repertoire and changes during HIV infection and treat-
ment.
The Vg2Vd2 T cell subset is an example of indirect or
bystander cell killing during HIV infection, and its impact
on immunity to seemingly unrelated pathogens. Destruc-
tion of Vg2Vd2 T cells and the critical elimination of the
Vg2-Jg1.2 expressing subset, likely accounts for the
mutual acceleration of HIV, malaria and tuberculosis dis-
eases, and may explain the specific of enhanced risk for
AIDS-related neoplasia. We continue efforts to compre-
hend this unusual T cell subset both as a model for the
impact of HIV in host immunity, and to define new targets
for immunomodulatory therapy.
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